Am­gen vet Lau­ra Hamill takes com­mer­cial reins at Gilead amid ex­ec­u­tive shake­up

In the lat­est move in a reshuf­fle of se­nior ex­ecs among the biggest play­ers in bio­phar­ma, Gilead has tapped long­time Am­gen vet Lau­ra Hamill to head its com­mer­cial team.

Hamill fills a po­si­tion va­cat­ed by the re­tire­ment of James Mey­ers, whose ca­reer tra­jec­to­ry was quite sim­i­lar to hers: He joined Gilead in 1996 as a re­gion­al sales di­rec­tor, climb­ing all the way up to EVP, com­mer­cial op­er­a­tions. Hamill had been with Am­gen since 2002, most re­cent­ly serv­ing as SVP, US busi­ness op­er­a­tions.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER